TrademarkDir
NEXZOL PHARMA
DEAD

Serial Number

87699430

Owner

NuRemedy Pharma LLC

Attorney

Sean MacKenzie

First Use Date

Jun 1, 2018

Filing Date

Nov 28, 2017

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

NEXZOL PHARMA Trademark

Serial Number: 87699430 • Registration: 5746594

NEXZOL PHARMA is a trademark filed by NuRemedy Pharma LLC on November 28, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

NuRemedy Pharma LLC (6 trademarks)

1180 North Town Center, Suite 100
Las Vegas, NV 89144

Entity Type: 16

Nexzol Pharma, Inc. (9 trademarks)

1001 Avenida Pico, Suite C-501
San Clemente, CA 92673

Entity Type: 03

Trademark Details

Filing Date

November 28, 2017

Registration Date

May 7, 2019

First Use Anywhere

June 1, 2018

First Use in Commerce

June 1, 2018

Published for Opposition

April 24, 2018

Cancellation Date

November 21, 2025

Goods & Services

Pharmaceutical research and development; Pharmaceutical research services

Marketing services in the field of pharmaceuticals; Sales management services; Sales promotion services; Business research and data analysis services in the field of pharmaceutical distribution

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 21, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 7, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
May 7, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 3, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 2, 2019 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 21, 2019 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2019 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 17, 2018 TCCA
SOU TEAS EXTENSION RECEIVED
Dec 17, 2018 EEXT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2018 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2018 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 22, 2018 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 20, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 19, 2018 AITU
USE AMENDMENT FILED
Aug 24, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 24, 2018 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 19, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 4, 2018 NONP
ASSIGNED TO LIE
Mar 18, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 12, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 12, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 12, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 12, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 12, 2018 CNEA
ASSIGNED TO EXAMINER
Mar 12, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2017 NWOS
NEW APPLICATION ENTERED
Dec 1, 2017 NWAP

Related Trademarks

More from this Owner

NEXREMEDY

NEXREMEDY

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

LOCALLY ENHANCED TRANSDERMAL SERUM (L.E.T.S.)

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL

ALPHAZOL